Applied Microbiology · 1973 · 38 citations · 10 references
Life SciencesMicrobiologyToxicologyDrug MetabolismMycologyPharmaceutical ToxicologyAlkaloid BiosynthesisFungal BiochemistryFungal Secondary MetabolitesMetabolite IdentificationPlant-pathogenic FungiBioactive Fungal MetabolitesFungal Bioactive CompoundsPenicillium MycotoxicosisPlant-associated Fungal MetabolitesToxic Mushroom Compounds
Brevianamide A, one of a novel group of alkaloids first obtained from Penicillium brevi-compactum, has also been isolated as a principal metabolite from two key isolates of P. viridicatum. Procedures for bioproduction and purification are described. This compound was not toxic when fed or injected into mice and had no antibiotic properties against several common bacterial and fungal microorganisms. Brevianamides A and B are among at least four yellow metabolites that may be formed by isolates of P. viridicatum.
10
<i>Penicillium viridicatum</i> Westling: a new source of ochratoxin A
W. van Walbeek, Peter Scott, J. Harwig et al. · Canadian Journal of Microbiology · 1969 · 107 citations